Print Page | Contact Us
Sub Laboratory Hypothyroidism and its Empirical Use of T3
Register Tell a Friend About This EventTell a Friend
 

 Export to Your Calendar 10/13/2017 to 10/27/2017
When: Oct 13, 2017 & Oct 27, 2017
6:00 - 7:30 pm PST
Where: Adobe Connect Webinar
United States
Presenter: Denis Wilson, MD
Contact: Rachel Weaver
949.329.8898


Online registration is available until: 10/27/2017
« Go to Upcoming Event List  

 Sub Laboratory Hypothyroidism and Its Empirical Use of T3

 Presented By Denis Wilson, MD

October 13, 2017 & October 27, 2017
6:00pm - 7:30pm PST


Recent research has demonstrated that much more regulation of the thyroid system occurs in the periphery than previously thought. The hypothalamic-pituitary-thyroid axis is responsible for maintaining an appropriate level of thyroid hormones that the cells can use to provide for normal metabolism. Just as vital, recent research has uncovered thyroid signaling pathways that regulate the thyroid system on a cellular level. The ubiquitin proteasome system controls the level of deiodinase enzyme, thereby determining T4 to T3 conversion. All this crucial intracellular activity is not measured by thyroid blood tests. This might explain why some people have low body temperatures and symptoms of low thyroid function that may warrant the empirical use of T3. A simple protocol for the empirical use of T3 in patients with low body temperatures and normal thyroid blood tests will be presented. Crucial principles of dosing and management that are specific to T3 therapy will be discussed and will focus on maximizing the benefit while minimizing the risk of T3 therapy.

 

At the conclusion of this 2-part series, participants will be able to:

  • Describe the physiology of thyroid hormone pathways and body temperature
  • Name 3 intracellular signaling pathways that direct the conversion of T4 to T3
  • Summarize the wide range of medical conditions that can be affected by body temperature and T3
  • Describe the intracellular physiology of thyroid hormones
  • Explain when and why T3 might be desirable as an empirical treatment
  • List the risks of T3 and the concerns of the American Thyroid Association regarding the use of T3

 

Member - $65  |  Nonmember - $85

 

Our Speaker

Denis Wilson, MD

Dr. Wilson graduated from the University of South Florida College of Medicine in 1985 and trained in Family Practice. Dr. Wilson specializes in optimizing peripheral thyroid function, body temperature, and well-being. Working with more than 5,000 patients, he has developed a new simplified paradigm for thyroid management and was the first doctor to use sustained-release liothyronine. For more than 20 years he has educated more than 2,500 physicians about the use of sustained-release liothyronine for patients with symptoms of low thyroid and low body temperature despite having normal blood tests. His novel treatment of using sustained-release T3 is now standard of care with a subsection of physicians practicing complementary and alternative medicine and his work is being taught in naturopathic medical schools.

Dr. Wilson is the author of 3 books, including the extensively referenced: Evidence-Based Approach to Restoring Thyroid Health. He is also the co-founder of an herbal supplement company that focuses on restoring health with certified organic formulas.

 



Registration Includes: 

Access to live webinar | Copy of webinar recording - no expiration dates & no view limits | Copies of handouts | CE Certificate (OBNM)